Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
3.
J Nephrol ; 25(5): 839-42, 2012.
Article in English | MEDLINE | ID: mdl-22252846

ABSTRACT

The incidence of neurotoxicity from calcineurin inhibitors varies by the organ transplanted. Akinetic mutism is characterized by the inability to perform voluntary movements and express language, without alterations in mental status. This process has been reported in neurotoxicity due to high serum levels of calcineurin inhibitors, but in rare cases, it presents as a form of tacrolimus toxicity after renal transplantation, despite normal serum levels. We report a clinical case of a renal transplant patient in whom reversible acute encephalopathy and akinetic mutism developed. Brain lesions appeared on magnetic resonance imaging, and the condition resolved after the drug was withdrawn.


Subject(s)
Akinetic Mutism/chemically induced , Brain/drug effects , Calcineurin Inhibitors , Immunosuppressive Agents/adverse effects , Kidney Transplantation/immunology , Neurotoxicity Syndromes/etiology , Tacrolimus/adverse effects , Akinetic Mutism/blood , Akinetic Mutism/diagnosis , Akinetic Mutism/pathology , Biomarkers/blood , Brain/metabolism , Brain/pathology , Drug Substitution , Everolimus , Female , Humans , Immunosuppressive Agents/blood , Immunosuppressive Agents/pharmacokinetics , Kidney Transplantation/adverse effects , Magnetic Resonance Imaging , Middle Aged , Neurologic Examination , Neurotoxicity Syndromes/blood , Neurotoxicity Syndromes/diagnosis , Neurotoxicity Syndromes/pathology , Sirolimus/administration & dosage , Sirolimus/analogs & derivatives , Tacrolimus/blood , Tacrolimus/pharmacokinetics , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...